Peptide record

TPDB09070

Antibacterial Anticancer Antifungal Hemolysis Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09070
Antibacterial Anticancer Antifungal Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 AFP-GFuse Antifungipept CAFPdb PD_Hemolysis
standard
No
A 19-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLFKLIPKAIKGLVKAIRK
Physicochemical Analysis
C108H187N27O20
NDCEQHMSTWY
K
2183.84
11.85
6
0
11
+6
1.08
0.647
148.95
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
2
A
1
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
3
I
3
L
5
K
0
M
2
F
1
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 3 K: 5 M: 0 F: 2 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
19
C108H187N27O20
2183.84
11.85
+6
1.08
0.647
Evidence Records 9 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

S. aurerus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against S. aurerus (MIC 4 ug/ml), E.coli (MIC 16 ug/ml), and C. albicans (MIC 4 ug/ml). Also inhibited four human cancer c
Evidence 2 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

E.coli

Source & Reference

dbAMP DRAMP

Other

Active against S. aurerus (MIC 4 ug/ml), E.coli (MIC 16 ug/ml), and C. albicans (MIC 4 ug/ml). Also inhibited four human cancer cell lines, H460, MB435s
Evidence 3 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

Active against S. aurerus (MIC 4 ug/ml), E.coli (MIC 16 ug/ml), and C. albicans (MIC 4 ug/ml). Also inhibited four human cancer cell lines, H460, MB435s, MCF-7 and PC3 at ~10 uM.
Evidence 4 Activity

Activity

MIC
Antifungal
4 µg/mL

Target

S. aurerus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against S. aurerus (MIC 4 ug/ml), E.coli (MIC 16 ug/ml), and C. albicans (MIC 4 ug/ml). Also inhibited four human cancer c
Evidence 5 Activity

Activity

MIC
Antifungal
16 µg/mL

Target

E.coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against S. aurerus (MIC 4 ug/ml), E.coli (MIC 16 ug/ml), and C. albicans (MIC 4 ug/ml). Also inhibited four human cancer cell lines, H460, MB435s
Evidence 6 Activity

Activity

MIC
Antifungal
4 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against S. aurerus (MIC 4 ug/ml), E.coli (MIC 16 ug/ml), and C. albicans (MIC 4 ug/ml). Also inhibited four human cancer cell lines, H460, MB435s, MCF-7 and PC3 at ~10 uM.
Evidence 7 Activity

Activity

100% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
100% Hemolysis | 64 | µg/mL | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities. | Toxins (Basel) | 2015
Evidence 8 Activity

Activity

% Hemolysis
Toxicity
100 %
Hemolytic
Hemolytic_activity: [Ref.25626077] 100% hemolysis at 32 µg/ml against horse red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Toxins (Basel). 2015 Jan 23 7(2):219-37. doi: 10.3390/toxins7020219.
Evidence 9 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis